OncoGel and Ovarian Cancer

Last Modified: February 12, 2006

Share article


Question

Dear OncoLink "Ask The Experts,"

Do you have any knowledge or experience with use of OncoGel to deliver paclitaxel directly into ovarian cancer masses? I have recurrent disease. Thank you.

Answer

Stephen C. Rubin, MD, Professor and Chief of the Division of Gynecologic Oncology, University of Pennsylvania Health System, responds:

OncoGel is an experimental, long-acting form of paclitaxel chemotherapy that is currently undergoing clinical testing for direct needle injection into tumor masses. We will await the results of these trials. However, direct needle injection is unfortunately not likely to play any role in this disease, as ovarian cancer typically spreads beyond the injected mass to involve many different areas and organs within the abdominal cavity.


News
Minority patients more willing than whites to expend their financial resources to prolong life

Apr 27, 2011 - Black cancer patients are more willing to expend their personal financial resources in order to extend life compared to white cancer patients, according to a study published online April 26 in Cancer.



I Wish You Knew

How an oncology social worker can improve your cancer experience

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More